KRSNAA DIAGNOSTICS
|
|
BOM : 543328     NSE : KRSNAA     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : NA |
Mar 28,2023 |
Price(EOD): ₹ 440.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 1,384.58 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KRSNAA DIAGNOSTICS | -2.2% | 14.6% | -12.3% |
APOLLO HOSPITALS ENTERPRISE | 1.2% | -3.2% | -7.7% |
MAX HEALTHCARE INSTITUTE | -3.7% | 4.2% | 34.2% |
FORTIS HEALTHCARE | 2.3% | -4.4% | -7.2% |
DR LAL PATHLABS | -1.1% | -6.7% | -30.7% |
NARAYANA HRUDAYALAYA | -1.5% | 2.4% | 5.6% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 1.5% | 0.2% | -0.3% |
ASTER DM HEALTHCARE | -1% | 1.9% | 31.3% |
RAINBOW CHILDRENS MEDICARE | -5.1% | -3.6% | NA |
FUNDAMENTAL ANALYSIS OF KRSNAA DIAGNOSTICS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KRSNAA DIAGNOSTICS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
22.65
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 61.13 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 2.03
P/B Calculated based on Book Value of Rs 682.37 Cr
[Latest Year - Mar2022 - Consolidated Results ] 3
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 462.14 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
16% 81% -31% |
SHARE PRICE MOMENTUM OF KRSNAA DIAGNOSTICS
KRSNAA DIAGNOSTICS vs SENSEX
DEBT OF KRSNAA DIAGNOSTICS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.06 1 -1.17 -0.04 |
0.06 - - 0.02 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KRSNAA DIAGNOSTICS
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KRSNAA DIAGNOSTICS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-3.94% -3.97% -11.8% -11.05% |
10.92% -2% -16.72% -16.47% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
KRSNAA DIAGNOSTICS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 1% | -1.3% | -11.5% |
S&P BSE ALLCAP | -1.5% | -3.2% | -3.4% |
S&P BSE MIDSMALLCAP | -2.8% | -4.3% | -4.1% |
S&P BSE SMALL CAP | -3.2% | -5.3% | -6.2% |
You may also like the below Video Courses
FAQ about KRSNAA DIAGNOSTICS
Is KRSNAA DIAGNOSTICS good for long term investment?
As on Mar 28,2023, the Fundamentals of KRSNAA DIAGNOSTICS look Poor and hence it may not be good for long term investment ! See Financial Performance of KRSNAA DIAGNOSTICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KRSNAA DIAGNOSTICS UnderValued or OverValued?
As on Mar 28,2023, KRSNAA DIAGNOSTICS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of KRSNAA DIAGNOSTICS ?
As on Mar 28,2023, the Intrinsic Value of KRSNAA DIAGNOSTICS is Rs. 381.12 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 381.12
Fair Value [Median EV / Sales Model] : Rs. 243.66
Fair Value [Median Price / Sales Model] : Rs. 639.76
Estimated Median Fair Value of KRSNAA DIAGNOSTICS : Rs. 381.12
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is KRSNAA DIAGNOSTICS trading at a Premium or Discount?
As on Mar 28,2023, KRSNAA DIAGNOSTICS is trading at a Premium of 16% based on the estimates of Median Intrinsic Value!